HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Tedisamil

HCID 65825
NotesReactions
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
90961-53-8
Standard SMILES
C1CCC2(C1)C1CN(CC3CC3)CC2CN(CC2CC2)C1
InChIKey
CTIRHWCPXYGDGF-UHFFFAOYSA-N
Molecular formula
C19H32N2
Average molar mass
288.5 g/mol
Monoisotopic mass
288.25654903

Overview

Tedisamil is a member of the class of diazabicyclononanes that is (1s,5s)-3,7-diazaspiro[bicyclo[3.3.1]nonane-9,1'-cyclopentane] in which the hydrogens at positions 3 and 7 are replaced by cyclopropylmethyl groups. It is a potassium channel blocker and an antiarrhythmic agent currently currently in development for the treatment of atrial fibrillation. It has a role as an anti-arrhythmia drug and a potassium channel blocker. It is a diazabicyclononane, a member of cyclopentanes, an azaspiro compound and a member of cyclopropanes.

Names & identifiers

Preferred name
Tedisamil
IUPAC
3,7-bis(cyclopropylmethyl)spiro[3,7-diazabicyclo[3.3.1]nonane-9,1'-cyclopentane]
English name
Tedisamil
Molecular formula
C19H32N2
Molecular weight
288.47

Names & synonyms

Tedisamil90961-53-8TedisamilumKC-8857KC88573,7-bis(cyclopropylmethyl)spiro[3,7-diazabicyclo[3.3.1]nonane-9,1'-cyclopentane]A5VAY2U3R83',7'-Bis(cyclopropylmethyl)spiro(cyclopentane-1,9'-(3,7)diazabicyclo(3.3.1)nonane)CHEBI:134747DTXSID30238334Spiro(cyclopentane-1,9'-(3,7)diazabicyclo(3.3.1)nonane), 3',7'-bis(cyclopropylmethyl)-3,7-di-(cyclopropylmethyl)-9,9-tetramethylene-3,7-diazabicyclo(3.3.1)nonane
Show more names
Pulzium
3,7-bis(cyclopropylmethyl)-3,7-diazaspiro[bicyclo[3.3.1]nonane-9,1'-cyclopentane]3,7-bis(cyclopropylmethyl)-3,7-diazaspiro(bicyclo(3.3.1)nonane-9,1'-cyclopentane)3,7-bis(cyclopropylmethyl)spiro(3,7-diazabicyclo(3.3.1)nonane-9,1'-cyclopentane)RefChem:187699C01BD06DTXCID50160825KC 8857Tedisamil (USAN)

Database identifiers

CAS
90961-53-8
PubChem CID
65825
DTXSID
DTXSID30238334

Properties

Computed structural properties

XLogP
3.9
Topological polar surface area
6.5 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
2
Rotatable bonds
4
Heavy atoms
21
Formal charge
0
Complexity
348

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LogP4.19

Physicochemical properties

Boiling point
372.452 · 372.452±10.00 °C(Press: 760.00 Torr)(predicted)
Density
1.097 · 1.097±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka
9.218 · 9.218±0.20(predicted)
FDA UNII
5 VAY2U3R8 · A5VAY2U3R8
ATC code
1 BD06 · C01BD06

Chemistry & industry

Pharmacology

ATC Code · 2 items

C - Cardiovascular system

QC - Cardiovascular system

Mechanism of ActionIt is hypothesized tedisamil prevents Ca2+ overload by the cAMP dependent SR Ca2+ uptake [PMID: 10707827].
MeSH Pharmacological Classification · 2 items

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).

Applications

UsesAntiarrhythmic agent (Ktchannel blocker).

Suppliers3 total

上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]
TargetMol中国(陶术生物)15002134094 · [email protected]
Additional notes · 1 item

DefinitionChEBI: Tedisamil is a member of the class of diazabicyclononanes that is (1s,5s)-3,7-diazaspiro[bicyclo[3.3.1]nonane-9,1'-cyclopentane] in which the hydrogens at positions 3 and 7 are replaced by cyclopropylmethyl groups. It is a potassium channel blocker and an antiarrhythmic agent currently currently in development for the treatment of atrial fibrillation. It has a role as an anti-arrhythmia drug and a potassium channel blocker. It is an azaspiro compound, a member of cyclopropanes, a member of cyclopentanes and a diazabicyclononane.

Related reactions

2 records
New reaction record
HRID 1110035 reaction equation
HRID 1110035As reactantuspto-grants-1994_06
HRID 1110036 reaction equation
HRID 1110036As reactantuspto-grants-1994_06

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
ChEMBL
CHEMBL113461
ChEBI
CHEBI:134747
UNII
A5VAY2U3R8
Nikkaji
J346.050I